This column provides readers with a taste of Cannin’s insights they offer to their members, including investment tips, trends, predictions and more. In this installment, we take a closer look at Village Farms to see if it is a strong buy.
This column provides readers with a taste of Cannin’s insights they offer to their members, including investment tips, trends, predictions and more. In this installment, we take a deeper dive into Columbia Care’s financials.
The post Why Should You Add Columbia Care to Your Cannabis Portfolio? appeared first on Cannabis Industry Journal.
We’re pleased to announce our new partnership with Cannin Investment Group, a cannabis investment analysis firm, on this new column. This collaboration will provide readers with a taste of Cannin’s insights and analysis that they offer to their members, including investment tips, trends, predictions, market updates and more.
The post 3 Cannabis Stocks That Can Gain Over 50% According to Analyst Estimates appeared first on Cannabis Industry Journal.
In this series, Aaron Green sits down and interviews a number of integrated cannabis companies and flower brands. In this Part 9, Green sits down with Andrew Thut, chief investment officer of 4Front Ventures, to learn about their business model, build vs. buy criteria and perspectives on industry trends.
Bespoke Financial is the nation’s first commercial lender focused on the cannabis industry. In this piece, we sit down with Founder & CEO George Mancheril to hear about his company, their successes and how the past few years have shaped the future of cannabis lending.
The post A Q&A with George Mancheril, Founder & CEO of Bespoke Financial appeared first on Cannabis Industry Journal.
In this article, Aaron Green sits down with Matt Hawkins, Co-Founder and Managing Partner at Entourage Effect Capital to learn more about his investment philosophy and get his perspective on recent trends in the cannabis industry.
The post A Q&A with Matt Hawkins, Co-Founder & Managing Partner at Entourage Effect Capital appeared first on Cannabis Industry Journal.
The rise of the SPAC-era and Canadian entry into the U.S. market will cause asset increases, but it is only the second chapter in the market expansion of cannabis.
The post Cannabis Revival and Year of the SPAC’s: What’s To Be Expected the Rest of 2021? appeared first on Cannabis Industry Journal.
There has been an explosion of interest in THCV recently, as well as a number of other uncommon cannabinoids. There will be big winners and losers in rare cannabinoid markets, but at the end of the day, the highest quality and lowest cost producers will capture most of these markets.
Prospects for the New Year are expected to continue the explosive year-end trend with a backlog of nearly $2 billion in deals heading into 2021. Growth is expected to be led by multi-state operators who have achieved scale, cleaned up their balance sheets and stockpiled dry powder for roll-up acquisitions.